中国社区医师Issue(28)：52-52,54,2.DOI:10.3969/j.issn.1007-614x.2014.28.31
索利那新联合坦索罗辛治疗Ⅲ型前列腺炎的临床价值分析
Clinical value analysis of solifenacin combined with tamsulosin in the treatment of type Ⅲ prostatitis
南勇 1毛琳琳 1李苏 1葛召营 1赵莉1
作者信息
- 1. 463100河南省遂平县人民医院泌尿外科
- 折叠
摘要
Abstract
Objective:To explore the clinical value of solifenacin combined with tamsulosin in the treatment of type Ⅲ prostatitis. Methods:94 cases with type Ⅲ prostatitis were selected from May 2012 to May 2014.They were divided into the observation group(n=47) and the control group(n=47).The observation group were treated with solifenacin combined with tamsulosin.The control group were treated with lincomycin.We compared the therapeutic effect,adverse reaction rate and mental status score after treatment of the two groups.Conclusion:In the observation group,the cure rate was 46.81%,which was significantly higher than the cure rate of 36.17% in the control group(P<0.05).In the observation group,the incidence of adverse reaction was 4.26%,which was significantly lower than that 14.89%of the control group(P<0.05).In the observation group,the SAS and the SDS score were significantly lower than those of the control group(P<0.05).Conclusion:Clinical value of solifenacin combined with tamsulosin in the treatment of type Ⅲ prostatitis is significant.It can effectively improve the clinical symptoms of patients,and it is worthy of promotion.关键词
Ⅲ型前列腺炎/索利那新/坦索罗辛/临床效果Key words
Type III prostatitis/Solifenacin/Tamsulosin/Clinical effect引用本文复制引用
南勇,毛琳琳,李苏,葛召营,赵莉..索利那新联合坦索罗辛治疗Ⅲ型前列腺炎的临床价值分析[J].中国社区医师,2014,(28):52-52,54,2.
